89 related articles for article (PubMed ID: 1931230)
1. Synthetic peptides allow discrimination of structural features of CD4(81-92) important for HIV-1 infection versus HIV-1-induced syncytium formation.
Lifson JD; Rausch DM; Kalyanaraman VS; Hwang KM; Eiden LE
AIDS Res Hum Retroviruses; 1991 Jun; 7(6):521-7. PubMed ID: 1931230
[TBL] [Abstract][Full Text] [Related]
2. Evidence by peptide mapping that the region CD4(81-92) is involved in gp120/CD4 interaction leading to HIV infection and HIV-induced syncytium formation.
Kalyanaraman VS; Rausch DM; Osborne J; Padgett M; Hwang KM; Lifson JD; Eiden LE
J Immunol; 1990 Dec; 145(12):4072-8. PubMed ID: 1701782
[TBL] [Abstract][Full Text] [Related]
3. A monoclonal antibody to the gp120-CD4 complex has differential effect on HIV-induced syncytium formation and viral infectivity.
Konopka K; Pretzer E; Celada F; Düzgüneş N
J Gen Virol; 1995 Mar; 76 ( Pt 3)():669-79. PubMed ID: 7897355
[TBL] [Abstract][Full Text] [Related]
4. Critical role of Arg59 in the high-affinity gp120-binding region of CD4 for human immunodeficiency virus type 1 infection.
Fontenot D; Jones JK; Hossain MM; Nehete PN; Vela EM; Dwyer VA; Jagannadha Sastry K
Virology; 2007 Jun; 363(1):69-78. PubMed ID: 17320923
[TBL] [Abstract][Full Text] [Related]
5. Synthetic CD4 exocyclics inhibit binding of human immunodeficiency virus type 1 envelope to CD4 and virus replication in T lymphocytes.
Zhang X; Gaubin M; Briant L; Srikantan V; Murali R; Saragovi U; Weiner D; Devaux C; Autiero M; Piatier-Tonneau D; Greene MI
Nat Biotechnol; 1997 Feb; 15(2):150-4. PubMed ID: 9035140
[TBL] [Abstract][Full Text] [Related]
6. Minimal sequence requirements for synthetic peptides derived from the V3 loop of the human immunodeficiency virus type 1 (HIV-1) to enhance HIV-1 binding to cells and infection.
Zanotto C; Calderazzo F; Dettin M; Di Bello C; Autiero M; Guardiola J; Chieco-Bianchi L; De Rossi A
Virology; 1995 Feb; 206(2):807-16. PubMed ID: 7856094
[TBL] [Abstract][Full Text] [Related]
7. Effects of CD4 synthetic peptides on HIV type I envelope glycoprotein function.
Repke H; Gabuzda D; Palù G; Emmrich F; Sodroski J
J Immunol; 1992 Sep; 149(5):1809-16. PubMed ID: 1354681
[TBL] [Abstract][Full Text] [Related]
8. Syncytium formation induced by human immunodeficiency virus type 1 isolates correlates with affinity for CD4.
Watkins BA; Crowley R; Davis AE; Louie AT; Reitz MS
J Gen Virol; 1997 Oct; 78 ( Pt 10)():2513-22. PubMed ID: 9349472
[TBL] [Abstract][Full Text] [Related]
9. Short synthetic peptides derived from viral proteins compete with HIV gp120 for the binding to CD4 receptors.
Chersi A; Pugliese O; Federico A; Viora M
Viral Immunol; 2000; 13(4):547-54. PubMed ID: 11192301
[TBL] [Abstract][Full Text] [Related]
10. An anti-human immunodeficiency virus multiple antigen peptide encompassing the cleavage region of the env precursor interferes with membrane fusion at a post-CD4 binding step.
Barbouche R; Decroly E; Kieny MP; Fenouillet E
Virology; 2000 Jul; 273(1):169-77. PubMed ID: 10891419
[TBL] [Abstract][Full Text] [Related]
11. Analysis of endoproteolytic cleavage and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane endoplasmic reticulum retention signal.
Raja NU; Vincent MJ; Jabbar MA
J Gen Virol; 1993 Oct; 74 ( Pt 10)():2085-97. PubMed ID: 8409933
[TBL] [Abstract][Full Text] [Related]
12. Binding to CD4 of synthetic peptides patterned on the principal neutralizing domain of the HIV-1 envelope protein.
Autiero M; Abrescia P; Dettin M; Di Bello C; Guardiola J
Virology; 1991 Dec; 185(2):820-8. PubMed ID: 1720590
[TBL] [Abstract][Full Text] [Related]
13. Differences in affinity of anti-CD4 monoclonal antibodies predict their effects on syncytium induction by human immunodeficiency virus.
Wilks D; Walker L; O'Brien J; Habeshaw J; Dalgleish A
Immunology; 1990 Sep; 71(1):10-5. PubMed ID: 2210798
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of a hydrophobic tripeptide on human immunodeficiency virus type 1 (HIV-1)-induced syncytium formation and viral infectivity.
Konopka K; Pretzer E; Düzgünes N
Biochem Biophys Res Commun; 1995 Mar; 208(1):75-81. PubMed ID: 7887968
[TBL] [Abstract][Full Text] [Related]
15. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5.
Trkola A; Dragic T; Arthos J; Binley JM; Olson WC; Allaway GP; Cheng-Mayer C; Robinson J; Maddon PJ; Moore JP
Nature; 1996 Nov; 384(6605):184-7. PubMed ID: 8906796
[TBL] [Abstract][Full Text] [Related]
16. Interactions of CCR5 and CXCR4 with CD4 and gp120 in human blood monocyte-derived dendritic cells.
Xiao X; Kinter A; Broder CC; Dimitrov DS
Exp Mol Pathol; 2000 Jun; 68(3):133-8. PubMed ID: 10816381
[TBL] [Abstract][Full Text] [Related]
17. The role of CD4 in HIV binding and entry.
Sattentau QJ; Moore JP
Philos Trans R Soc Lond B Biol Sci; 1993 Oct; 342(1299):59-66. PubMed ID: 7904348
[TBL] [Abstract][Full Text] [Related]
18. The CD4-gp120 interaction and AIDS pathogenesis.
Capon DJ; Ward RH
Annu Rev Immunol; 1991; 9():649-78. PubMed ID: 1910691
[TBL] [Abstract][Full Text] [Related]
19. Role of the HIV type 1 glycoprotein 120 V3 loop in determining coreceptor usage.
Verrier F; Borman AM; Brand D; Girard M
AIDS Res Hum Retroviruses; 1999 May; 15(8):731-43. PubMed ID: 10357469
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human immunodeficiency virus infection by the lectin jacalin and by a derived peptide showing a sequence similarity with gp120.
Favero J; Corbeau P; Nicolas M; Benkirane M; Travé G; Dixon JF; Aucouturier P; Rasheed S; Parker JW; Liautard JP
Eur J Immunol; 1993 Jan; 23(1):179-85. PubMed ID: 8419169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]